3D Technologies Can Improve Breast Cancer Diagnosis

3D Technologies Can Improve Breast Cancer Diagnosis
shutterstock_111823859A team of scientists at the U.S. Food and Drug Administration (FDA), led by Division Director Kyle Myers, a physicist with a Ph.D. in optical sciences, are developing a line of research to study the next generation of screening and diagnostic devices. The regulatory work being developed by the FDA team, which also includes Aldo Badano, Ph.D., a world-renowned expert in display evaluation technology, and Brian Garra, M.D., a diagnostic radiologist doing research in regulatory science at FDA, will hopefully lead to the use of three-dimensional (3D) images to help doctors locate hidden tumors and improve cancer diagnosis. The central focus of their research is breast cancer screening devices, which are moving from traditional two-dimensional (2D) screening to 3D breast tomosynthesis (artificially creates 3D images of the breast using 2D images), 3D ultrasound and breast computerized tomography (CT). However, this type of technology is still very experimental and it will take years before it becomes a standard of care. Among all of the different 3D technologies being developed, the FDA has already approved The Selenia Dimensions 3D System, which allows for 3D breast tomosynthesis images of the breast for cancer diagnosis, and the GE Healthcare SenoClaire, which combi
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.